BANNOCKBURN, Ill., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 43rd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Monday, January 13, 2025, including a presentation at 1:30pm PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com.
About Option Care Health
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at OptionCareHealth.com.
For Investor Inquiries:
Mike Shapiro
Chief Financial Officer
T: (312) 940-2538
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$22.81 |
| Daily Change: | -0.11 -0.48 |
| Daily Volume: | 613,905 |
| Market Cap: | US$3.880B |
October 30, 2024 July 31, 2024 April 23, 2024 February 22, 2024 January 08, 2024 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
